RS

Radha Singh

Active Director Director DIN 09844495
DIN 09844495 First appointment Jan 2023 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value •••• Premium profile

About Radha Singh

Data last updated:

Radha Singh is a Director at Minslear Biotech Private Limited (since 2023). The company operates in Electrnoics. Minslear Biotech Private Limited reported revenue of ₹3.2 Lakh (FY 2024).

DIN 09844495
Primary Designation Director
Industry Electrnoics
First Appointment 02 Jan 2023
Oldest Company Age 6 yrs
Largest company Minslear Biotech Private Limited · ₹3.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Minslear Biotech Private Limited U52603RJ2020PTC069828
Director02 Jan 20232020₹3.2 Lakh (FY 2024)Active

Board colleagues of Radha Singh

NameDINCompanyDesignation
Payal Singh08807232Minslear Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Minslear Biotech Private Limited
Premium access

Shareholding and investment profile for Radha Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Radha Singh

Radha Singh currently holds 1 directorship: Minslear Biotech Private Limited (Director, since 02 Jan 2023, revenue ₹3.2 Lakh (FY 2024)).

Radha Singh was first appointed on 02 Jan 2023 as Director at Minslear Biotech Private Limited.

The current boards of Radha Singh's companies include Payal Singh (Minslear Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available